相关实验视频

Updated: May 20, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

二次治疗的差异是否解释了前列腺癌查对死亡率的影响? - - 一个随机查试验

Joona Lampela¹, Kirsi Talala², Teuvo L J Tammela¹

¹Tampere University, Prostate Cancer Research Center, Tampere, Finland.

Urologic oncology

|April 12, 2025

概括

前列腺癌 (PC) 查降低了死亡率. 在ERSPC研究的芬兰部分,对抗割的PC的治疗方法在查和对照臂之间没有显著差异.

科学领域:

在瘤学瘤学.
泌尿器科泌尿器科泌尿器科泌尿器科
公共卫生公共卫生

背景情况:

关于前列腺癌查的欧洲随机研究 (ERSPC) 显示,基于PSA的查降低了前列腺癌 (PC) 死亡率.
ERSPC的芬兰部分 (FinRSPC) 旨在评估试验手臂之间对抗割PC的治疗变化.

研究的目的:

为了确定是否对抗割的PC的治疗方法在FinRSPC内的查和控制臂之间有所不同.
分析治疗频率,持续时间和割耐药PC后雄激素剥夺疗法 (ADT) 的时间.

主要方法:

从医疗记录和国家数据库 (1996-2015) 中回顾性分析临床数据.
包括在坦佩雷大学医院诊断出PC并开始ADT的男性.
评估使用考克斯回归进行治疗时间分析的抗割PC治疗方法.

主要成果:

在查和控制臂之间没有观察到对抗割的PC治疗的分布或时间的统计学上显著差异.
在ADT启动后,对抗割PC的治疗开始没有显著差异 (HR:1.00;P=0.998).
在第一个,第二个和后来的治疗线上观察到类似的治疗模式.

结论:

在FinRSPC中观察到的PC死亡率的减少不太可能是由于研究手臂之间对抗割的PC的差异治疗.
结果表明治疗一致性,尽管研究的局限性包括小样本大小和单一中心范围.

关键词:

对割的抗性有所抵抗.前列腺癌是什么意思前列腺癌是什么意思查检查查检查查检查治疗方法治疗方法

更多相关视频

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

相关概念视频

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...